Manufacturer

FSSAI Defers Earlier Coffee-Chicory Labelling Requirement and Issues Revised Front-of-Pack Declaration

Posted by: Prabhas Chakraborty July 29, 2026

CDSCO Releases Guidance Document on Medical Device Software

Posted by: Prabhas Chakraborty July 29, 2026

7
Comments Off on CDSCO Releases Guidance Document on Medical Device Software
29th July, 2026

India Strengthens Global Food Standards at the 49th Codex Alimentarius Commission

Posted by: Prabhas Chakraborty July 27, 2026

7
Comments Off on India Strengthens Global Food Standards at the 49th Codex Alimentarius Commission
27th July, 2026

Applications Invited for Medical Device Clinical Studies and Import Reduction Schemes under SMDI

Posted by: Prabhas Chakraborty July 27, 2026

Department of Pharmaceuticals Invites Applications for Medical Device Cluster Support under SMDI

Posted by: Prabhas Chakraborty July 27, 2026

Central Bureau of Narcotics Revises Instructions for Submission of Quarterly Returns

Posted by: Prabhas Chakraborty July 27, 2026

7
Comments Off on Central Bureau of Narcotics Revises Instructions for Submission of Quarterly Returns
27th July, 2026

FSSAI Northern Regional Office Holds Stakeholder Interaction with Food Business Operators to Enhance Compliance and Ease of Doing Business

Posted by: Prabhas Chakraborty July 27, 2026

Frequently Asked Questions on Migration to IS/IEC 62368-1:2023

Posted by: Hitesh Gupta July 27, 2026

7
Comments Off on Frequently Asked Questions on Migration to IS/IEC 62368-1:2023
27th July, 2026

What's New 2?

Regulation/Guidelines

India as a Cosmetic Manufacturing Hub: CDSCO, BIS, and the Regulatory Enablers for Global Manufacturers

The Strategic Shift For most global Cosmetic brands, India's regulatory journey has begun with import registration — the COS-2 pathway explored throughout this series. But for a growing cohort of...

5th August, 2026

Regulation/Guidelines

Post-Market Surveillance Under Medical Device Rules, 2017

Regulatory approval is often treated as the finish line. In reality, for Medical Device and IVD manufacturers in India, it marks the start of an equally demanding obligation: Post-Market Surveillance...

4th August, 2026

Regulation/Guidelines

How to Sequence Global and India Market Entry for Medical Devices Without Creating Regulatory Rework

One of the most avoidable and expensive mistakes in Medical Device commercialisation is Regulatory rework — the process of going back to redo documentation, testing, or submissions because the original...

3rd August, 2026

Regulation/Guidelines

Blood and Plasma-Derived Product Approvals in India: Regulatory and Quality Expectations

Blood and Plasma-derived Medicinal products (PDMPs) — including immunoglobulins, albumin, clotting factors, and hyperimmune globulins — occupy a critical and highly regulated niche in India's healthcare system. These products are...

31st July, 2026

Manufacturer

Manufacturer

FSSAI Defers Earlier Coffee-Chicory Labelling Requirement and Issues Revised Front-of-Pack Declaration

CDSCO Releases Guidance Document on Medical Device Software

India Strengthens Global Food Standards at the 49th Codex Alimentarius Commission

Applications Invited for Medical Device Clinical Studies and Import Reduction Schemes under SMDI

Department of Pharmaceuticals Invites Applications for Medical Device Cluster Support under SMDI

Central Bureau of Narcotics Revises Instructions for Submission of Quarterly Returns

FSSAI Northern Regional Office Holds Stakeholder Interaction with Food Business Operators to Enhance Compliance and Ease of Doing Business

Frequently Asked Questions on Migration to IS/IEC 62368-1:2023

For Importers To India

Drug

Biologicals

Food Supplements

Medical Device

IVD

Food

Cosmetic

Other

For Manufacturer in India

Drug

Biologicals

Food Supplements

Food

Medical Device

IVD

Cosmetic

Other